Underdosing of antiparkns drug/centr musc-tone depr, sequela

This code signifies the long-term effects or complications arising from a patient's insufficient intake or administration of medications used to treat Parkinson's disease or other central muscle-tone depressants. These sequelae are persistent conditions that develop as a direct result of the underdosing event, rather than the acute underdosing itself.

Apply this code when documenting chronic neurological or musculoskeletal issues, such as worsening tremors, rigidity, bradykinesia, or dystonia, that are directly attributable to a past period of inadequate antiparkinsonism drug or central muscle-tone depressant therapy. This code is appropriate for conditions that are no longer in the acute phase of underdosing but represent its lasting impact.

• Always use this code as a secondary diagnosis, following the code for the specific sequela (e.g., G20 for Parkinson's disease).
• Ensure documentation clearly links the current sequela to a previous underdosing event.
• Do not use for acute underdosing; refer to the appropriate acute underdosing code for initial encounters.